Goldsite Diagnostics Inc., is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents. Goldsite offers clinical instruments such as advanced medical laboratory analyzers that provide accurate and timely results to aid clinical diagnosis.
Goldsite provide full portfolio of biomarker in vitro diagnostic assays performed at clinical laboratory for COVID-19, infectious diseases, diabetes and more. Our current products include more than 50 assays, from inflammation, diabetes, rheumatoid diseases, immune disorders, hormones to cardiac markers.
Goldsite Diagnostics at MEDICA 2026 | World Premiere of GSH-120 COMPANY NEWS GSH-120 Debuts at MEDICA 2026 High-Throughput Ion-Exchange HPLCHbA1c Analyzer Hall 1 · Stand B56 | 16–19 November 2026 | Messe Düsseldorf, Germany
READ MORE
Diabetes and Chronic Kidney Disease (CKD) Co-management: A Medical Guideline Review HPLC HbA1c testing + specific-protein testing as a combined solution Reference guidelines: KDIGO 2024 · ADA Standards of Care 2025 World Diabetes Day feature · 14 November 2026 Contents 1. Background: The need fo
READ MORE